Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

AmerisourceBergen will pay $2.56bn for compounder PharMEDium Healthcare

AmerisourceBergen has announced plans to buy drug compounding firm PharMEDium Healthcare Holdings from private equity group, Clayton, Dubilier & Rice.

Evotec hopeful US NCI contract will prompt more compound management deals

Evotec has been hired to manage candidate drug compounds by the US National Cancer Institute (NCI) under an agreement the CRO hopes will help it win further contracts.

BASF new efficiency drive may involve job cuts

BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.

Chiltern seeking metabolism expertise for new unit after hiring ex PPD exec

Got experience in endocrinology and metabolism indications R&D? Chiltern has added a new offering and says it is looking to hire.

Size critical: Siegfried completes takeover of BASF's API business

Siegfried Holdings has completed the takeover of BASF CEO Kurt Brock called the firm’s “relatively successful” pharma business.

Biocon buys Vizag API plant from supplier Acacia

Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...